---
figid: PMC6337474__ijms-20-00083-g001
figlink: /pmc/articles/PMC6337474/figure/ijms-20-00083-f001/
number: Figure 1
caption: 'Top left: Wnt binds to the Frizzled receptor (Fz) and the LRP5/6 co-receptor.
  LRP5/6 and Fz deactivate the β-catenin destruction complex, which leads to accumulation
  of β-catenin. β-catenin translocates into the nucleus, where it regulates transcription
  of Wnt target genes with TCF/LEF. Sclerostin inhibits binding of Wnt to LRP5/6.
  PTH binds to LRP6 and causes an Wnt-independent deactivation of the β-catenin destruction
  complex. bottom: Wnt promotes the osteoblastic lineage and inhibits osteoclastogenesis
  and apoptosis. BMP is a strong promoter of osteoblastic differentiation. PTH acts
  through the PTH1R receptor in the osteoblastic lineage and has an inhibiting effect
  on sclerostin expression. APT and TPT work through selective activation of PTH1R
  activation. ROMO binds sclerostin. DENO binds RANKL and prevents RANK activation.
  Apo, Apoptosis; APT, Abaloparatide, parathyroid hormone-related protein analogue;
  β-cat. DC, β-catenin destruction complex, targets β-catenin for ubiquitination and
  subsequent degradation in the proteasome; BMP2/7, Bone morphogenetic protein 2 and
  7; DENO, Denosumab, monoclonal antibody against RANKL; ECM, Extracellular matrix;
  Fz, Frizzled receptor, G-protein coupled receptor, target for Wnt; LRP5/6, Low-density
  lipoprotein receptor-related protein 5 or 6; LRP6, Low-density lipoprotein receptor-related
  protein 6; MSC, Mesenchymal stem cell; Obl, Osteoblast; Ocl, Osteoclast; Ocy, Osteocyte;
  PTH, Parathyroid hormone; TPT, Teriparatide, peptide Fragment of PTH; PTH1R, parathyroid
  hormone 1 receptor; RANK, Receptor Activator of NF-κB; RANKL, Receptor Activator
  of NF-κB Ligand; ROMO, Romosozumab, monoclonal antibody against sclerostin; Scl,
  Sclerostin; TCF/LEF, T cell factor/lymphoid enhancer factor; Wnt, Wingless-related
  integration site/Wnt signalling pathway.'
pmcid: PMC6337474
papertitle: Anabolic Therapies in Osteoporosis and Bone Regeneration.
reftext: Gabriele Russow, et al. Int J Mol Sci. 2019 Jan;20(1):83.
pmc_ranked_result_index: '154190'
pathway_score: 0.955985
filename: ijms-20-00083-g001.jpg
figtitle: 'Top left: Wnt binds to the Frizzled receptor (Fz) and the LRP5/6 co-receptor'
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6337474__ijms-20-00083-g001.html
  '@type': Dataset
  description: 'Top left: Wnt binds to the Frizzled receptor (Fz) and the LRP5/6 co-receptor.
    LRP5/6 and Fz deactivate the β-catenin destruction complex, which leads to accumulation
    of β-catenin. β-catenin translocates into the nucleus, where it regulates transcription
    of Wnt target genes with TCF/LEF. Sclerostin inhibits binding of Wnt to LRP5/6.
    PTH binds to LRP6 and causes an Wnt-independent deactivation of the β-catenin
    destruction complex. bottom: Wnt promotes the osteoblastic lineage and inhibits
    osteoclastogenesis and apoptosis. BMP is a strong promoter of osteoblastic differentiation.
    PTH acts through the PTH1R receptor in the osteoblastic lineage and has an inhibiting
    effect on sclerostin expression. APT and TPT work through selective activation
    of PTH1R activation. ROMO binds sclerostin. DENO binds RANKL and prevents RANK
    activation. Apo, Apoptosis; APT, Abaloparatide, parathyroid hormone-related protein
    analogue; β-cat. DC, β-catenin destruction complex, targets β-catenin for ubiquitination
    and subsequent degradation in the proteasome; BMP2/7, Bone morphogenetic protein
    2 and 7; DENO, Denosumab, monoclonal antibody against RANKL; ECM, Extracellular
    matrix; Fz, Frizzled receptor, G-protein coupled receptor, target for Wnt; LRP5/6,
    Low-density lipoprotein receptor-related protein 5 or 6; LRP6, Low-density lipoprotein
    receptor-related protein 6; MSC, Mesenchymal stem cell; Obl, Osteoblast; Ocl,
    Osteoclast; Ocy, Osteocyte; PTH, Parathyroid hormone; TPT, Teriparatide, peptide
    Fragment of PTH; PTH1R, parathyroid hormone 1 receptor; RANK, Receptor Activator
    of NF-κB; RANKL, Receptor Activator of NF-κB Ligand; ROMO, Romosozumab, monoclonal
    antibody against sclerostin; Scl, Sclerostin; TCF/LEF, T cell factor/lymphoid
    enhancer factor; Wnt, Wingless-related integration site/Wnt signalling pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - C9orf3
  - TNFRSF11A
  - CTNNB1
  - PTH
  - WNT3A
  - WNT2
  - MSC
  - BMP2
  - WNT6
  - WNT7A
  - WNT3
  - WNT8A
  - WNT5B
  - WNT1
  - WNT7B
  - WNT9A
  - WNT5A
  - WNT8B
  - WNT16
  - WNT10B
  - WNT10A
  - WNT4
  - WNT9B
  - WNT11
  - WNT2B
  - TNFSF11
genes:
- word: Apo
  symbol: AP-O
  source: hgnc_alias_symbol
  hgnc_symbol: C9orf3
  entrez: '84909'
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: PTH
  symbol: PTH
  source: hgnc_symbol
  hgnc_symbol: PTH
  entrez: '5741'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: MSC
  symbol: MSC
  source: hgnc_symbol
  hgnc_symbol: MSC
  entrez: '9242'
- word: BMP2/7.
  symbol: BMP2
  source: hgnc_symbol
  hgnc_symbol: BMP2
  entrez: '650'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: '----RANKL-->'
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
chemicals: []
diseases: []
---
